Product Details
Product Name:
Eciruciclib |
CAS No.:
1868086-40-1 |
Purity:
97.51% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | Eciruciclib |
Description | Eciruciclib is an inhibitor of CDK with antitumor properties. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 4.5 mg/mL (9.21 mM), Sonication and heating to 60℃ are recommended.
|
Keywords | Eciruciclib | inhibit | CDK | Cyclin dependent kinase | Inhibitor |
Inhibitors Related | Ribociclib | Ro-3306 | Rafoxanide | AT7519 | CASIN | Palbociclib | GW 441756 | Abemaciclib | Dinaciclib | Abemaciclib methanesulfonate |
Related Compound Libraries | Anti-Pancreatic Cancer Compound Library | Bioactive Compound Library | Kinase Inhibitor Library | Anti-Breast Cancer Compound Library | Inhibitor Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:205749-56-0
$93.00 / 1mg
-
CAS:27220-47-9
$39.00 / 500mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |